Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis
暂无分享,去创建一个
Liu Wang | J. Wen | H. Dai | Wei Li | Guihai Feng | Zheng Hu | Baoyang Hu | D. Song | Peipei Liu | Zai Wang | Lei Wang | Jie Hao | Qi Zhou | Zhongwen Li | Wenjing Liu | Jun Wu | Chunjing Feng | Shengnan Yang | Yukai Wang | Yan Huo | Lingmin Liang | Ng Shyh‐Chang | Ronghua Jin | G. Stacey | Baojie Guo | Ting-ting Gao | Yan‐Hong Xiao | Ying Li | Yanxia Chen | L. Peng
[1] M. Pittenger,et al. Mesenchymal stem cell perspective: cell biology to clinical progress , 2019, npj Regenerative Medicine.
[2] A. Serrano-Mollar. Cell Therapy in Idiopathic Pulmonary Fibrosis† , 2018, Medical sciences.
[3] Qi Zhou,et al. SIRT6 deficiency results in developmental retardation in cynomolgus monkeys , 2018, Nature.
[4] Guoji Guo,et al. Mapping human pluripotent stem cell differentiation pathways using high throughput single-cell RNA-sequencing , 2018, Genome Biology.
[5] Xiaolong Wei,et al. Transplantation of human matrix metalloproteinase-1 gene-modified bone marrow-derived mesenchymal stem cell attenuates CCL4-induced liver fibrosis in rats , 2018, International journal of molecular medicine.
[6] L. Richeldi,et al. Idiopathic pulmonary fibrosis: pathogenesis and management , 2018, Respiratory Research.
[7] Daniel Brodie,et al. Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment , 2018, JAMA.
[8] D. S. Kim,et al. Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis , 2018, Respiratory Research.
[9] Huanping Zhou,et al. [Research progress of mesenchymal stem cells in the treatment of ALI]. , 2017, Zhonghua wei zhong bing ji jiu yi xue.
[10] Liu Wang,et al. Accreditation of Biosafe Clinical-Grade Human Embryonic Stem Cells According to Chinese Regulations , 2017, Stem cell reports.
[11] J. Hare,et al. Route of Delivery Modulates the Efficacy of Mesenchymal Stem Cell Therapy for Myocardial Infarction: A Meta-Analysis of Preclinical Studies and Clinical Trials , 2017, Circulation research.
[12] Vasilis Ntziachristos,et al. Fluorescence molecular tomography of DiR-labeled mesenchymal stem cell implants for osteochondral defect repair in rabbit knees , 2017, European Radiology.
[13] Anders Larsson,et al. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. , 2016, JAMA.
[14] P. Thompson,et al. Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells. , 2015, Journal of visualized experiments : JoVE.
[15] Steven L Salzberg,et al. HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.
[16] Charles F. Burant,et al. Impact of Anesthesia and Euthanasia on Metabolomics of Mammalian Tissues: Studies in a C57BL/6J Mouse Model , 2015, PloS one.
[17] A. Azuma,et al. A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis , 2015 .
[18] B. Thompson,et al. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. , 2015, The Lancet. Respiratory medicine.
[19] M. Matthay,et al. Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis. , 2014, The Lancet. Respiratory medicine.
[20] Z. Jia,et al. Cell-based therapy in lung regenerative medicine , 2014, Regenerative Medicine Research.
[21] L. Ortiz,et al. Cell therapy trials for lung diseases: progress and cautions. , 2013, American journal of respiratory and critical care medicine.
[22] Q. Hao,et al. Adult stem cells for acute lung injury: Remaining questions and concerns , 2013, Respirology.
[23] Yufang Shi,et al. How mesenchymal stem cells interact with tissue immune responses. , 2012, Trends in immunology.
[24] J. Kurtzberg,et al. Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[25] Takeshi Johkoh,et al. American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .
[26] R. Stewart,et al. A mesoderm-derived precursor for mesenchymal stem and endothelial cells. , 2010, Cell stem cell.
[27] Cole Trapnell,et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.
[28] E. J. Lee,et al. Novel embryoid body-based method to derive mesenchymal stem cells from human embryonic stem cells. , 2010, Tissue engineering. Part A.
[29] Aaron R. Quinlan,et al. Bioinformatics Applications Note Genome Analysis Bedtools: a Flexible Suite of Utilities for Comparing Genomic Features , 2022 .
[30] Nathaniel S. Hwang,et al. In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells , 2008, Proceedings of the National Academy of Sciences.
[31] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[32] L. Ortiz,et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury , 2007, Proceedings of the National Academy of Sciences.
[33] M. Salto‐Tellez,et al. Derivation of Clinically Compliant MSCs from CD105+, CD24− Differentiated Human ESCs , 2007, Stem cells.
[34] Diane P. Martin,et al. Incidence and outcomes of acute lung injury. , 2005, The New England journal of medicine.
[35] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[36] N. Socci,et al. Derivation of Multipotent Mesenchymal Precursors from Human Embryonic Stem Cells , 2005, PLoS medicine.
[37] J. Chiche,et al. Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome. , 2003, Critical care medicine.
[38] H. T. Moriya,et al. Nonlinearity of respiratory mechanics during bronchoconstriction in mice with airway inflammation. , 2002, Journal of applied physiology.
[39] P. Suter,et al. Tumor necrosis factor-alpha and angiostatin are mediators of endothelial cytotoxicity in bronchoalveolar lavages of patients with acute respiratory distress syndrome. , 2002, American journal of respiratory and critical care medicine.
[40] M. Pittenger,et al. Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.
[41] J. Thomson,et al. Embryonic stem cell lines derived from human blastocysts. , 1998, Science.
[42] G. Laurent,et al. The acute respiratory distress syndrome: fibrosis in the fast lane , 1998, Thorax.
[43] J. Iredale,et al. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. , 1996, Gastroenterology.
[44] D. Schuppan,et al. Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. , 1994, The American journal of pathology.